Who owns MRNA
Institutions that file 13Fs hold 79% of the shares
Shares they hold, quarter on quarter
+3.4%
147 new, 247 added, 224 cut, 92 sold out
Top 10 holders
64%
of the shares institutions hold
A 13F lists the long positions of managers with more than $100M in US stocks. It shows the last day of a quarter and is filed up to 45 days later. Two managers can report the same shares, so totals can count some shares twice.
Institutional owners
The 25 biggest holders
| Holder | Shares | Value | % of company | From Mar 31, 2026 |
|---|---|---|---|---|
| FMR LLC | 51.86M | $3.6B | 12.82% | Added +13.5% |
| BlackRock, Inc. | 30.60M | $2.1B | 7.56% | Added +3.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 23.21M | $1.6B | 5.74% | Added +1.5% |
| Capital World Investors | 22.28M | $1.6B | 5.51% | Added +19.1% |
| BAILLIE GIFFORD & CO | 18.21M | $1.3B | 4.50% | Reduced -8.9% |
| STATE STREET CORP | 15.73M | $1.1B | 3.89% | Added +5.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 15.58M | $1.1B | 3.85% | Held |
| GEODE CAPITAL MANAGEMENT, LLC | 9.71M | $678.8M | 2.40% | Added +2.9% |
| MORGAN STANLEY | 9.54M | $668.0M | 2.36% | Added +12.6% |
| Theleme Partners LLP | 8.06M | $564.3M | 1.99% | Held |
| TWO SIGMA INVESTMENTS, LP | 7.19M | $503.8M | 1.78% | Reduced -20.8% |
| Invesco Ltd. | 5.78M | $404.8M | 1.43% | Added +20.8% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.59M | $391K | 1.38% | Added +656.8% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.84M | $338.9M | 1.20% | Added +2.2% |
| GOLDMAN SACHS GROUP INC | 4.67M | $327.2M | 1.15% | Reduced -29.3% |
| Flagship Pioneering, LLC | 4.63M | $324.4M | 1.14% | Held |
| UBS Group AG | 4.46M | $312.6M | 1.10% | Added +1.3% |
| BNP PARIBAS FINANCIAL MARKETS | 4.38M | $306.5M | 1.08% | Added +1.4% |
| NORGES BANK | 3.03M | $211.9M | 0.75% | New |
| NORTHERN TRUST CORP | 2.99M | $209.1M | 0.74% | Added +1.1% |
| BANQUE PICTET & CIE SA | 2.70M | $189.0M | 0.67% | Reduced -1.8% |
| DIMENSIONAL FUND ADVISORS LP | 2.47M | $172.9M | 0.61% | Added +15.8% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.46M | $172.4M | 0.61% | Added +4.4% |
| Merck & Co., Inc. | 2.31M | $161.6M | 0.57% | Held |
| CITIGROUP INC | 2.17M | $151.6M | 0.54% | Added +46.3% |
Show the other 15 holders
This quarter
Who bought and who sold the most shares
Bought the most shares
- FMR LLC +6.19M
- PRICE T ROWE ASSOCIATES INC /MD/ +4.85M
- Capital World Investors +3.58M
- NORGES BANK +3.03M, new
- BAMCO INC /NY/ +1.99M, new
- MORGAN STANLEY +1.07M
- Invesco Ltd. +996K
- BlackRock, Inc. +964K
- STATE STREET CORP +865K
- CITIGROUP INC +685K
Sold the most shares
- Alyeska Investment Group, L.P. -3.49M
- FIRST TRUST ADVISORS LP -2.37M
- GOLDMAN SACHS GROUP INC -1.93M
- TWO SIGMA INVESTMENTS, LP -1.89M
- BAILLIE GIFFORD & CO -1.78M
- RENAISSANCE TECHNOLOGIES LLC -881K, sold out
- D. E. Shaw & Co., Inc. -642K
- MILLENNIUM MANAGEMENT LLC -581K
- VOLORIDGE INVESTMENT MANAGEMENT, LLC -486K, sold out
- JPMORGAN CHASE & CO -480K
Superinvestors
Superinvestors holding MRNA
None of the followed investors held MRNA in their latest 13F.
More than 5%
13D filings: owners who may push for change
No Schedule 13D about MRNA in the last year.